Literature DB >> 27506618

Nuclear receptors as pharmacological targets, where are we now?

David H Volle1,2,3,4.   

Abstract

Knowledge of integrative physiology is a major challenge for scientists, as even small deregulation could lead to diseases. Cells communicate with each other to control many processes such as growth, migration, survival, or differentiation. Such interaction could be achieved via several mechanisms either through cell-cell interactions and/or through the signaling of molecules that bind to receptors on the membrane or in the target cells. The produced molecules could have either autocrine, paracrine stimulations, or even act on distant organs (endocrine signaling).

Keywords:  Nuclear receptors; Pathophysiology; Therapeutic drugs

Mesh:

Substances:

Year:  2016        PMID: 27506618     DOI: 10.1007/s00018-016-2327-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  6 in total

Review 1.  Orphan nuclear receptors: from gene to function.

Authors:  V Giguère
Journal:  Endocr Rev       Date:  1999-10       Impact factor: 19.871

2.  Epigenetic transgenerational actions of endocrine disruptors and male fertility.

Authors:  Matthew D Anway; Andrea S Cupp; Mehmet Uzumcu; Michael K Skinner
Journal:  Science       Date:  2005-06-03       Impact factor: 47.728

Review 3.  Hypogonadotropic hypogonadism in subjects with DAX1 mutations.

Authors:  Unmesh Jadhav; Rebecca M Harris; J Larry Jameson
Journal:  Mol Cell Endocrinol       Date:  2011-06-13       Impact factor: 4.102

Review 4.  Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection.

Authors:  Jorma Toppari; Helena E Virtanen; Katharina M Main; Niels E Skakkebaek
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-10

5.  The orphan nuclear receptor small heterodimer partner mediates male infertility induced by diethylstilbestrol in mice.

Authors:  David H Volle; Mélanie Decourteix; Erwan Garo; Judy McNeilly; Patrick Fenichel; Johan Auwerx; Alan S McNeilly; Kristina Schoonjans; Mohamed Benahmed
Journal:  J Clin Invest       Date:  2009-11-02       Impact factor: 14.808

6.  Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis.

Authors:  Natalia Gomez-Ospina; Carol J Potter; Rui Xiao; Kandamurugu Manickam; Mi-Sun Kim; Kang Ho Kim; Benjamin L Shneider; Jennifer L Picarsic; Theodora A Jacobson; Jing Zhang; Weimin He; Pengfei Liu; A S Knisely; Milton J Finegold; Donna M Muzny; Eric Boerwinkle; James R Lupski; Sharon E Plon; Richard A Gibbs; Christine M Eng; Yaping Yang; Gabriel C Washington; Matthew H Porteus; William E Berquist; Neeraja Kambham; Ravinder J Singh; Fan Xia; Gregory M Enns; David D Moore
Journal:  Nat Commun       Date:  2016-02-18       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.